Flavonoid binding to human serum albumin. 2010

Alessandro Bolli, and Maria Marino, and Gerald Rimbach, and Gabriella Fanali, and Mauro Fasano, and Paolo Ascenzi
Department of Biology, University Roma Tre, Viale Guglielmo Marconi 446, I-00146 Roma, Italy.

Dietary flavonoid may have beneficial effects in the prevention of chronic diseases. However, flavonoid bioavailability is often poor probably due to their interaction with plasma proteins. Here, the affinity of daidzein and daidzein metabolites as well as of genistein, naringenin, and quercetin for human serum albumin (HSA) has been assessed in the absence and presence of oleate. Values of the dissociation equilibrium constant (K) for binding of flavonoids and related metabolites to Sudlow's site I range between 3.3x10(-6) and 3.9x10(-5)M, at pH 7.0 and 20.0 degrees C, indicating that these flavonoids are mainly bound to HSA in vivo. Values of K increase (i.e., the flavonoid affinity decreases) in the presence of saturating amounts of oleate by about two folds. Present data indicate a novel role of fatty acids as allosteric inhibitors of flavonoid bioavailability, and appear to be relevant in rationalizing the interference between dietary compounds, food supplements, and drugs.

UI MeSH Term Description Entries
D007529 Isoflavones 3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. 3-Benzylchroman-4-One,3-Benzylidene-4-Chromanone,Homoisoflavone,Homoisoflavones,Isoflavone,Isoflavone Derivative,3-Benzylchroman-4-Ones,3-Benzylidene-4-Chromanones,Isoflavone Derivatives,3 Benzylchroman 4 One,3 Benzylchroman 4 Ones,3 Benzylidene 4 Chromanone,3 Benzylidene 4 Chromanones,Derivative, Isoflavone,Derivatives, Isoflavone
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011794 Quercetin A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin. 3,3',4',5,7-Pentahydroxyflavone,Dikvertin
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D012709 Serum Albumin A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules. Plasma Albumin,Albumin, Serum
D044950 Flavanones A group of FLAVONOIDS characterized with a 4-ketone. 2-Phenyl-Benzopyran-4-Ones,2 Phenyl Benzopyran 4 Ones

Related Publications

Alessandro Bolli, and Maria Marino, and Gerald Rimbach, and Gabriella Fanali, and Mauro Fasano, and Paolo Ascenzi
May 2005, Journal of agricultural and food chemistry,
Alessandro Bolli, and Maria Marino, and Gerald Rimbach, and Gabriella Fanali, and Mauro Fasano, and Paolo Ascenzi
March 2012, Journal of agricultural and food chemistry,
Alessandro Bolli, and Maria Marino, and Gerald Rimbach, and Gabriella Fanali, and Mauro Fasano, and Paolo Ascenzi
August 1980, Naunyn-Schmiedeberg's archives of pharmacology,
Alessandro Bolli, and Maria Marino, and Gerald Rimbach, and Gabriella Fanali, and Mauro Fasano, and Paolo Ascenzi
December 2006, Journal of biomolecular structure & dynamics,
Alessandro Bolli, and Maria Marino, and Gerald Rimbach, and Gabriella Fanali, and Mauro Fasano, and Paolo Ascenzi
June 1988, International journal of clinical pharmacology, therapy, and toxicology,
Alessandro Bolli, and Maria Marino, and Gerald Rimbach, and Gabriella Fanali, and Mauro Fasano, and Paolo Ascenzi
January 2014, Iranian journal of pharmaceutical research : IJPR,
Alessandro Bolli, and Maria Marino, and Gerald Rimbach, and Gabriella Fanali, and Mauro Fasano, and Paolo Ascenzi
January 1989, Chemical & pharmaceutical bulletin,
Alessandro Bolli, and Maria Marino, and Gerald Rimbach, and Gabriella Fanali, and Mauro Fasano, and Paolo Ascenzi
September 1973, Journal of pharmaceutical sciences,
Alessandro Bolli, and Maria Marino, and Gerald Rimbach, and Gabriella Fanali, and Mauro Fasano, and Paolo Ascenzi
June 1972, The Journal of pharmacy and pharmacology,
Alessandro Bolli, and Maria Marino, and Gerald Rimbach, and Gabriella Fanali, and Mauro Fasano, and Paolo Ascenzi
January 2013, BioFactors (Oxford, England),
Copied contents to your clipboard!